AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive ...
Boston, April 27, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence is fundamentally reshaping lung cancer therapeutics, with breakthrough technologies demonstrating 85–95% accuracy in biomarker identification and attracting unprecedented investment …